Please use this identifier to cite or link to this item: https://biore.bio.bg.ac.rs/handle/123456789/448
DC FieldValueLanguage
dc.contributor.authorBataveljić, Danijelaen_US
dc.contributor.authorMilošević, Milenaen_US
dc.contributor.authorRadenović, Lidijaen_US
dc.contributor.authorAnđus, Pavleen_US
dc.date.accessioned2019-07-03T12:10:05Z-
dc.date.available2019-07-03T12:10:05Z-
dc.date.issued2014-01-01-
dc.identifier.issn2314-6133-
dc.identifier.urihttps://biore.bio.bg.ac.rs/handle/123456789/448-
dc.description.abstractRecently neuroinflammation has gained a particular focus as a key mechanism of ALS. Several studies in vivo as well as in vitro have nominated immunoglobulin G (IgG) isolated from ALS patients as an active contributor to disease onset and progression. We have shown that ALS IgG affects astroglial Ca2+ excitability and induces downstream activation of phosphatidylinositol 3-kinase. These studies were hampered by a lack of knowledge of the pathway of entry of immune factors in the CNS. Our MRI data revealed the blood-brain barrier BBB leakage and T cell infiltration into brain parenchyma in ALS G93A rats. Since astrocyte ensheathes blood vessel wall contributing to BBB stability and plays an important role in ALS pathogenesis, we have studied astrocytic membrane proteins water channel aquaporin-4 and the inwardly rectifying potassium channel. In this review, we will summarize data related to BBB disruption with particular emphasis on impaired function of astrocytes in ALS. We will discuss implication of membrane proteins expressed on astrocytic endfeet, aquaporin-4, and inwardly rectifying potassium channel in the pathology of ALS. In addition to ALS-specific IgGs, these membrane proteins are proposed as novel biomarkers of the disease. © 2014 Danijela Bataveljic et al.en_US
dc.language.isoenen_US
dc.relation.ispartofBioMed Research Internationalen_US
dc.titleNovel molecular biomarkers at the blood-brain barrier in ALSen_US
dc.typeArticleen_US
dc.identifier.doi10.1155/2014/907545-
dc.identifier.pmid24949481-
dc.identifier.scopus2-s2.0-84901805842-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/84901805842-
item.cerifentitytypePublications-
item.grantfulltextrestricted-
item.openairetypeArticle-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
crisitem.author.deptChair of General Physiology and Biophysics-
crisitem.author.deptChair of General Physiology and Biophysics-
crisitem.author.deptChair of General Physiology and Biophysics-
crisitem.author.orcid0000-0002-6138-6766-
crisitem.author.orcid0000-0002-6632-0483-
crisitem.author.orcid0000-0002-8468-8513-
Appears in Collections:Journal Article
Files in This Item:
File Description SizeFormat Existing users please
22 Novel-molecular-biomarkers-at-the-bloodbrain-barrier-in-ALS.pdf1.61 MBAdobe PDF
    Request a copy
Show simple item record

SCOPUSTM   
Citations

28
checked on Apr 29, 2024

Page view(s)

10
checked on May 4, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.